Lexeo Therapeutics (LXEO) Operating Income: 2022-2024
Historic Operating Income for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to -$105.8 million.
- Lexeo Therapeutics' Operating Income rose 1.47% to -$15.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$68.5 million, marking a year-over-year change of. This contributed to the annual value of -$105.8 million for FY2024, which is 54.37% down from last year.
- Per Lexeo Therapeutics' latest filing, its Operating Income stood at -$105.8 million for FY2024, which was down 54.37% from -$68.5 million recorded in FY2023.
- In the past 5 years, Lexeo Therapeutics' Operating Income registered a high of -$60.5 million during FY2022, and its lowest value of -$105.8 million during FY2024.
- Its 3-year average for Operating Income is -$78.3 million, with a median of -$68.5 million in 2023.
- Data for Lexeo Therapeutics' Operating Income shows a maximum YoY tumbled of 54.37% (in 2024) over the last 5 years.
- Over the past 3 years, Lexeo Therapeutics' Operating Income (Yearly) stood at -$60.5 million in 2022, then decreased by 13.23% to -$68.5 million in 2023, then plummeted by 54.37% to -$105.8 million in 2024.